Skip to main content

Table 1 Patient characteristics and tumour parameters

From: Expression of FOXA1 and GATA-3 in breast cancer: the prognostic significance in hormone receptor-negative tumours

Variable Data
Age at diagnosis (years)  
   Mean and standard deviation 57 ± 14.2
   Range 59 (minimum 30; maximum 89)
Tumour size (mm)  
   Mean and standard deviation 32 ± 21 mm
   Range 145 (minimum 5; maximum 150)
Lymphovascular invasion  
   Present 111 (44.6)
   Absent 111 (44.6)
   Not assessed 27 (10.8)
Lymph node sage  
   Negative 111 (44.6)
   1 to 3 lymph nodes 57 (22.9)
   >3 lymph nodes 54 (21.7)
   Not assessed 27 (10.8)
Tumour grade  
   Grade I 51 (20.5)
   Grade II 116 (46.6)
   Grade III 82 (32.9)
Histology  
   Invasive ductal carcinoma (not otherwise specified) 208 (83.5)
   Invasive lobular carcinoma 7 (2.8)
   Mixed 3 (1.2)
   Tubular 3 (1.2)
   Medullary 8 (3.3)
   Other special types 20 (8.0)
Nottingham Prognostic Index  
   <3.4 46 (18.5)
   3.4 to 5.4 106 (42.6)
   >5.4 55 (22.0)
   Not assessed 42 (16.9)
Oestrogen receptor-α status  
   Positive 141 (56.6)
   Negative 107 (43.0)
   Unknown 1 (0.4)
Progesterone receptor status  
   Positive 89 (35.8)
   Negative 154 (61.8)
   Unknown 6 (2.4)
Human epidermal growth factor receptor 2 status  
   Positive 42 (16.9)
   Negative 201 (80.7)
   Unknown 6 (2.4)
  1. Data presented as n (%) unless stated otherwise.